Abstract
Several morphological and functional imaging techniques are usually used to
detect residual/recurrent medullary thyroid carcinoma (MTC) with variable
results; currently, there is growing interest in positron emission tomography
(PET) methodology. Herein, we report our experience of and a literature review
about the comparison of different positron emission tomography (PET) tracers in
patients with residual/recurrent MTC. (18)F-DOPA PET/CT seems to be the most
useful imaging method to detect recurrent MTC lesions, performing better than
(18)F-FDG and (68)Ga-somatostatin analogs PET/CT. (18)F-FDG may complement
(18)F-DOPA in patients with aggressive tumors. (68)Ga-somatostatin analogs PET/CT
may be useful to select patients who could benefit from radioreceptor therapy.
The information provided by the various PET tracers reflects different metabolic
pathways, and may help to select the most appropriate treatment
Lingua originale | English |
---|---|
pagine (da-a) | 385-393 |
Numero di pagine | 9 |
Rivista | Recent Results in Cancer Research |
Volume | 194 |
Stato di pubblicazione | Pubblicato - 2013 |
Keywords
- PET/CT
- medullary thyroid carcinoma